Detalles de la búsqueda
1.
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
N Engl J Med
; 388(26): 2444-2455, 2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379135
2.
Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.
Intest Res
; 22(2): 172-185, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38720466
3.
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Inflamm Bowel Dis
; 2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459910
4.
Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.
Antimicrob Agents Chemother
; 55(7): 3476-84, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21537018
Resultados
1 -
4
de 4
1
Próxima >
>>